Bortezomib plus dexamethasone for rituximab-resistant PLA2R+ membranous nephropathy
Sofiane Salhi, David Ribes, Magali Colombat, Françoise Fortenfant, Stanislas Faguer
Topics & Concepts
RituximabMedicineBortezomibMembranous nephropathyDexamethasonePlasma cellInternal medicineRefractory (planetary science)AntibodySalvage therapyPlasmapheresisMonoclonalOncologyImmunologyMonoclonal antibodyGlomerulonephritisChemotherapyKidneyMultiple myelomaBiologyAstrobiologyRenal Diseases and GlomerulopathiesAutoimmune Bullous Skin DiseasesVasculitis and related conditions